微RNA-451a是主要抑郁症障碍的候选生物标志物和治疗点
Panpan Hu1, Qiuchen Cao1, Hu Feng1
1Jiangsu Key Laboratory of Neurodegeneration, Nanjing Medical University, Nanjing, Jiangsu, China.
General psychiatry
|February 2, 2024
概括
微RNA-451a (miR-451a) 在严重抑郁症 (MDD) 中降低. 在小鼠中恢复miR-451a改善了类似抑郁症的行为和保护大脑细胞,这表明它是一个治疗目标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 重度抑郁症 (MDD) 与微RNA (miRNA) 失调有关,但潜在的机制尚不清楚.
- 特定的miRNAs,包括microRNA-451a (miR-451a),已与MDD病理生理学有关.
研究的目的:
- 研究miR-451a在与抑郁症相关的病理和行为中的作用和机制.
- 探索miR-451a作为MDD的潜在生物标志物和治疗标.
主要方法:
- 在MDD患者和慢性克制压力 (CRS) 的小鼠模型中评估了血清miR-451a水平.
- miR-451a在使用腺相关病毒载体的CRS小鼠的中间前额皮质 (mPFC) 中过度表达.
- 进行行为,病理和分子分析以阐明机制.
主要成果:
- 在MDD患者中,血清miR-451a水平较低,与抑郁症严重程度负相关.
- miR-451a在CRS小鼠的mPFC下调,其水平与抑郁行为负相关.
- 在mPFC中,miR-451a的过度表达改善了CRS小鼠的抑郁症样表型和树突性脊柱损失.
- 发现miR-451a通过向转录因子2来抑制皮质otropin释放因子受体1的表达,从而保持树突脊柱的可塑性.
结论:
- miR-451a对与抑郁症相关的行为和病理有保护作用.
- miR-451a通过调节皮质otropin释放因子受体1通路来起作用.
- miR-451a 是一个有前途的生物标志物候选者和主要抑郁症治疗点.
更多相关视频
10:37Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
Published on: November 30, 2016
8.3K
05:19Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
2.3K
相关概念视频
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
01:23Antidepressant Drugs: MAOIs and Other Agents
234
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
234